Pharmaceuticals - Multinational
No data available
No data available
No data available
Particulars (in ₹ Cr.) | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Total Revenue | - | - | - | - | - |
Total Expenses | 0.30 | - | - | - | - |
Profit Before Tax | -0.30 | - | - | - | - |
Profit After Tax | -0.30 | - | - | - | - |
Operating Profit after Depreciation | -0.30 | - | - | - | - |
Particulars (in ₹ Cr.) | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Fixed Assets | - | - | - | - | - |
Total Non Current Assets | - | - | - | - | - |
Total Current Assets | 1.70 | - | - | - | - |
TOTAL ASSETS | 1.70 | - | - | - | - |
Total Shareholder's Fund | 1.70 | - | - | - | - |
Particulars (in ₹ Cr.) | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Net Cash from Operating Activities | -0.40 | - | - | - | - |
Net Cash used in Investing Activities | - | - | - | - | - |
Net Cash used in Financing Activities | 2 | - | - | - | - |
No data available
Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-09 |
---|---|---|---|---|
Total Revenue | 159.90 | 164.40 | 211.20 | 210.30 |
Total Expenses | 96.80 | 100.80 | 129.40 | 115.70 |
Profit Before Tax | 61.20 | 38.90 | 83.90 | 95.20 |
Profit After Tax | 45 | 29 | 62.70 | 71.20 |
Operating Profit after Depreciation | 67.30 | 64.40 | 84.80 | 95.90 |
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Sanofi Consumer Healthcare India Ltd | ₹4,713.20 | ₹10,854.79 |
Sun Pharmaceuticals Industries Ltd | ₹1,745.25 | ₹4,18,743.94 |
Divis Laboratories Ltd | ₹5,733.60 | ₹1,52,209.07 |
Cipla Ltd | ₹1,458.15 | ₹1,17,762.24 |
Torrent Pharmaceuticals Ltd | ₹3,357.15 | ₹1,13,616.11 |
Mankind Pharma Ltd | ₹2,488.40 | ₹1,02,663.15 |
03 Jan 2025, 01:08 pm
12 Nov 2024, 02:50 pm
06 Nov 2024, 04:10 pm